Healx
3 employees
Artificial Intelligence (AI)
Series C · $134.0M
Company details
Team Size3
IndustryArtificial Intelligence (AI)
Funding
Total raised
$134.0M
Last stage
Series C
Investors
Balderton Capital
Total raised
$134.0M
Last stage
Series C
Investors
David Brown
Formerly global head of drug discovery at Roche. Co-inventor of Viagra. Has invented multiple drugs that reached market, generating over $40 billion in revenue.
Nick Sireau
Co-founder of Healx, focused on rare disease drug discovery.
Tim Guilliams
PhD in Biophysical Neuroscience from the University of Cambridge. Tech entrepreneur and social entrepreneur passionate about leveraging AI to accelerate treatments for rare diseases. Also Co-Founder and Chair of the Cambridge Rare Disease Network.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.